Changing shape: evolving an outsourced bioanalytical strategy to support the changing needs of drug development

Bioanalysis. 2017 Aug;9(15):1135-1137. doi: 10.4155/bio-2017-0098. Epub 2017 Aug 1.

Authors

Craig Stovold¹, Fiona Milligan², Glen Hawthorne¹, Colin Pattison², Amanda Wilson¹

Affiliations

¹ Translational Biomarkers & Bioanalysis, Drug Safety & Metabolism, IMED, AstraZeneca, Fleming Building (B623), Babraham Research Campus, C/O Darwin Building 310, Milton Science Park, Cambridge, CB4 OWG, UK.
² Bioanalysis & Immunology, Charles River Laboratories, Tranent, Edinburgh, EH33 2NE, UK.

PMID: 28763237
DOI: 10.4155/bio-2017-0098

No abstract available

Keywords: GLP; alliance; bioanalysis; outsourcing; partnership; strategy.

MeSH terms

Biological Assay / standards
Drug Development / standards*
Drug Industry / standards*
Humans
Laboratories / standards
Outsourced Services / standards*